The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

Capricor Therapeutics (NASDAQ:CAPR) received the Orphan Drug designation from the U.S. FDA for its lead cell therapy candidate, Deramiocel, to treat becker muscular dystrophy. With its orphan drug ...

Many parents said they were afraid of noninvasive ventilation, with some citing inaccurate concerns about ventilation devices.